AMRYT PHARMA PLC
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 89.22B | ||||||
| 40.49B | ||||||
| 32.79B | ||||||
| 26.23B | ||||||
| 14.52B |
